United States - English - NLM (National Library of Medicine)

skinmed international co., ltd. - titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w) - titanium dioxide 0.1462 g in 1 g - sunscreen helps prevent sunburn

United States - English - NLM (National Library of Medicine)

skinmed international co., ltd. - titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w) - titanium dioxide 0.1462 g in 1 g - sunscreen helps prevent sunburn

United States - English - NLM (National Library of Medicine)

skinmed international co., ltd. - titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w) - titanium dioxide 0.1462 g in 1 g - sunscreen helps prevent sunburn

United States - English - NLM (National Library of Medicine)

skinmed international co., ltd. - dimethicone (unii: 92ru3n3y1o) (dimethicone - unii:92ru3n3y1o) - skin protectant temporarily protects chapped or cracked skin prevent and protect from the drying effects of wind and cold weather

United States - English - NLM (National Library of Medicine)

skinmed international co., ltd. - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w) - sunscreen helps prevent sunburn

India - English - Central Drugs Standard Control Organization

la drug - methylcobalamin - od tab - 1500mcg - 10

India - English - Central Drugs Standard Control Organization

la pharma - methylcobalamin,alphalipoic acid,vit.b6,folic acid - cap - 1500mcg,100mg,3mg,1.5mg - 10

India - English - Central Drugs Standard Control Organization

anikem lab. - lansoprazole - cap - 30mg - 10

European Union - English - EMA (European Medicines Agency)

mylan s.a.s. - lopinavir/ritonavir - hiv infections - antivirals for systemic use, - lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children above the age of 2 years.the choice of lopinavir/ritonavir to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.

European Union - English - EMA (European Medicines Agency)

accord healthcare s.l.u. - docetaxel - head and neck neoplasms, carcinoma, non-small-cell lung, adenocarcinoma, prostatic neoplasms, breast neoplasms - antineoplastic agents, - breast cancerdocetaxel accord in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with:operable node-positive breast cancer;operable node-negative breast cancer.for patients with operable node-negative breast cancer, adjuvant treatment should be restricted to patients eligible to receive chemotherapy according to internationally established criteria for primary therapy of early breast cancer.docetaxel accord in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition.docetaxel accord monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent.docetaxel accord in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer w